These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24867419)

  • 1. Recent advances in the oral delivery of insulin.
    Ramesan RM; Sharma CP
    Recent Pat Drug Deliv Formul; 2014; 8(2):155-9. PubMed ID: 24867419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.
    Rekha MR; Sharma CP
    Int J Pharm; 2013 Jan; 440(1):48-62. PubMed ID: 22503954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral insulin-delivery system for diabetes mellitus.
    Kanzarkar M; Pathak PP; Vaidya M; Brumlik C; Choudhury A
    Pharm Pat Anal; 2015 Jan; 4(1):29-36. PubMed ID: 25565158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent patents on oral insulin delivery.
    Navgire SD; Satpute AS; Pandey S; Patil AT
    Recent Pat Drug Deliv Formul; 2014; 8(3):202-5. PubMed ID: 24981288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microencapsulation techniques to develop formulations of insulin for oral delivery: a review.
    Cárdenas-Bailón F; Osorio-Revilla G; Gallardo-Velázquez T
    J Microencapsul; 2013; 30(5):409-24. PubMed ID: 23234361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal uptake of insulin nanoparticles: facts or myths?
    Lopes MA; Abrahim BA; Seiça R; Veiga F; Rodrigues CR; Ribeiro AJ
    Curr Pharm Biotechnol; 2014; 15(7):629-38. PubMed ID: 25219866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral insulin delivery: existing barriers and current counter-strategies.
    Gedawy A; Martinez J; Al-Salami H; Dass CR
    J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
    Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
    Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems.
    Card JW; Magnuson BA
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G956-67. PubMed ID: 21921287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue targeted nanocapsids for oral insulin delivery via drink.
    Chen CC; Baikoghli MA; Cheng RH
    Pharm Pat Anal; 2018 May; 7(3):121-127. PubMed ID: 29676653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
    Ismail R; Csóka I
    Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and advances in nanoparticle-based oral insulin delivery.
    Ramesan RM; Sharma CP
    Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Insulin: Myth or Reality.
    Kumar V; Choudhry I; Namdev A; Mishra S; Soni S; Hurkat P; Jain A; Jain D
    Curr Diabetes Rev; 2018; 14(6):497-508. PubMed ID: 28637407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
    Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
    J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eligen insulin--a system for the oral delivery of insulin for diabetes.
    Hoffman A; Qadri B
    IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
    Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
    J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
    Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral insulin delivery: how far are we?
    Fonte P; Araújo F; Reis S; Sarmento B
    J Diabetes Sci Technol; 2013 Mar; 7(2):520-31. PubMed ID: 23567010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.